Published in

Royal Society of Chemistry, RSC Advances, 29(11), p. 17669-17682, 2021

DOI: 10.1039/d1ra00050k

Links

Tools

Export citation

Search in Google Scholar

Characterization of an active ingredient made of nanoscale iron(oxyhydr)oxide for the treatment of hyperphosphatemia

Journal article published in 2021 by Magdalena Bäumler ORCID, Sebastian P. Schwaminger ORCID, Daniela von der Haar-Leistl, Simon J. Schaper ORCID, Peter Müller-Buschbaum ORCID, Friedrich E. Wagner, Sonja Berensmeier
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Green circle
Postprint: archiving allowed
Upload
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

The combination of different analytical methods, supported by TEM, DLS, SAXS, Mössbauer spectroscopy, and SQUID, allows more accurate characterization of a new nanoscale active ingredient based on iron(oxyhydr)oxide against hyperphosphatemia.